MA41177A - Utilisation de ligands des récepteurs sigma dans l'arthrose - Google Patents

Utilisation de ligands des récepteurs sigma dans l'arthrose

Info

Publication number
MA41177A
MA41177A MA041177A MA41177A MA41177A MA 41177 A MA41177 A MA 41177A MA 041177 A MA041177 A MA 041177A MA 41177 A MA41177 A MA 41177A MA 41177 A MA41177 A MA 41177A
Authority
MA
Morocco
Prior art keywords
arthrosis
receptor ligands
sigma receptor
sigma
ligands
Prior art date
Application number
MA041177A
Other languages
English (en)
Inventor
Manuel Merlos-Roca
Jose-Miguel Vela-Hernandez
Daniel Zamanillo-Castanedo
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of MA41177A publication Critical patent/MA41177A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA041177A 2014-12-15 2015-12-14 Utilisation de ligands des récepteurs sigma dans l'arthrose MA41177A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382519 2014-12-15
EP15000261 2015-01-28

Publications (1)

Publication Number Publication Date
MA41177A true MA41177A (fr) 2017-10-24

Family

ID=54936995

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041177A MA41177A (fr) 2014-12-15 2015-12-14 Utilisation de ligands des récepteurs sigma dans l'arthrose

Country Status (18)

Country Link
US (1) US20170273948A1 (fr)
EP (1) EP3233078A1 (fr)
JP (1) JP2017537104A (fr)
KR (1) KR20170096130A (fr)
CN (1) CN106999473A (fr)
AU (1) AU2015365954A1 (fr)
BR (1) BR112017010845A2 (fr)
CA (1) CA2968153A1 (fr)
IL (1) IL252339A0 (fr)
MA (1) MA41177A (fr)
MX (1) MX2017007792A (fr)
PH (1) PH12017500910A1 (fr)
RU (1) RU2017125134A (fr)
SG (1) SG11201704530UA (fr)
TN (1) TN2017000201A1 (fr)
TW (1) TW201630607A (fr)
WO (1) WO2016096125A1 (fr)
ZA (1) ZA201703503B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016315396B2 (en) * 2015-09-02 2021-05-27 Laboratorios Del Dr. Esteve, S.A. 1-(4-(2-((1-(3,4-difluorophenyl)-1 H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone salts
WO2018011169A1 (fr) * 2016-07-12 2018-01-18 Laboratorios Del Dr. Esteve, S.A. Utilisation de ligands des récepteurs sigma contre la douleur post-herpétique.
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
EP4059498A1 (fr) * 2021-03-16 2022-09-21 Centre Hospitalier Universitaire Vaudois (CHUV) Procédés et compositions pour le traitement de pathologies associées à une hyperminéralisation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1634872A1 (fr) * 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Dérivés de pyrazole en tant qu'inhibiteurs des récepteurs sigma
KR101352012B1 (ko) * 2004-08-27 2014-01-15 라보라토리오스 델 드라. 에스테브.에스.에이. 시그마 수용체 저해제
EP1634873A1 (fr) * 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Inhibiteurs des récepteurs sigma
JP2008179541A (ja) * 2005-05-02 2008-08-07 Mochida Pharmaceut Co Ltd 神経因性疼痛治療薬
GB0516168D0 (en) * 2005-08-05 2005-09-14 Cambridge Lab Ireland Ltd Pharmaceutical compounds
WO2007098953A1 (fr) * 2006-03-01 2007-09-07 Laboratorios Del Dr. Esteve, S.A. Derives pyrazole utilises en tant qu'inhibiteurs du recepteur sigma
EP1847542A1 (fr) * 2006-04-21 2007-10-24 Laboratorios del Dr. Esteve S.A. Dérivés de spiro[benzopyran] ou de spiro[benzofuran] comme antagonistes du récepteur sigma
EP1921071A1 (fr) * 2006-11-10 2008-05-14 Laboratorios del Dr. Esteve S.A. 1,2,3-Triazoles en tant qu'inhibiteurs du récepteur sigma
EP1921073A1 (fr) * 2006-11-10 2008-05-14 Laboratorios del Dr. Esteve S.A. 1,2,4-Triazoles en tant qu'inhibiteurs du récepteur sigma
EP1982987A1 (fr) * 2007-04-16 2008-10-22 Laboratorios del Dr. Esteve S.A. Dérivés de spiro-pyrano-pyrazole
EP2113501A1 (fr) * 2008-04-25 2009-11-04 Laboratorios Del. Dr. Esteve, S.A. Pyrazoles de 5-Methyl-1-(naphthalen-2-YL)-1H- utiles en tant qu'inhibiteurs de récepteur sigma
EP2335688A1 (fr) * 2009-11-25 2011-06-22 Laboratorios Del. Dr. Esteve, S.A. Compositions pharmaceutiques comprenant des ligands du récepteur sigma
EP2353598A1 (fr) * 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Ligands sigma pour utilisation dans la prévention et/ou le traitement de la douleur post-opératoire
EP2395003A1 (fr) * 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Composés pyrazoliques en tant qu'inhibiteurs du récepteur sigma
EP2415471A1 (fr) * 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Utilisation de ligands sigma dans l'hyperalgie induite par opioïdes

Also Published As

Publication number Publication date
AU2015365954A1 (en) 2017-06-08
EP3233078A1 (fr) 2017-10-25
KR20170096130A (ko) 2017-08-23
PH12017500910A1 (en) 2017-12-18
WO2016096125A1 (fr) 2016-06-23
ZA201703503B (en) 2019-11-27
JP2017537104A (ja) 2017-12-14
TW201630607A (zh) 2016-09-01
TN2017000201A1 (en) 2018-10-19
IL252339A0 (en) 2017-07-31
BR112017010845A2 (pt) 2017-12-26
SG11201704530UA (en) 2017-07-28
CN106999473A (zh) 2017-08-01
CA2968153A1 (fr) 2016-06-23
RU2017125134A3 (fr) 2019-05-30
MX2017007792A (es) 2017-09-18
US20170273948A1 (en) 2017-09-28
RU2017125134A (ru) 2019-01-17

Similar Documents

Publication Publication Date Title
HUE055465T2 (hu) PD-L1 ellenes humán antitestek
IL248579B (en) Response of microbiome to substances
EP3466435C0 (fr) Agent améliorant la fonction cérébrale
CL2014002680S1 (es) Gancho
CL2014002681S1 (es) Gancho
PL3234071T3 (pl) Piec
FR3027415B1 (fr) Modulateur de phase electro­optique
EP3204028A4 (fr) Composition synergique pour l'arthrose
IL251345B (en) Compositions for use in the treatment of peri-implantitis
BR112016022703A2 (pt) fecho de contato destacável
IL248792A0 (en) Hsp70 modulators and methods for making and using the same
ZA201703503B (en) Use of sigma receptor ligands in osteoarthritis
EP3733837A4 (fr) Agent favorisant l'agrégation de cellules
ES1109830Y (es) " senalador de prendas"
EP3327089A4 (fr) Pigment particulaire fonctionnel
FR3017513B1 (fr) Bavoir jetable
TH1601000113A (th) สารประกอบมีฤทธิ์ทางการรักษาโรคและวิธีการใช้สารเหล่านั้น
TH1501006596A (th) สารประกอบไบเฮทเทอโรแอริล และการใช้งานของพวกมัน
UA30788S (uk) Каструля-чавунець пічний
FI10638U1 (fi) Hierontakoukku
TH1501004190B (th) เครื่องนุ่งห่มแบบบัสเทียร์ที่มีความสามารถในการรองรับ
UA28865S (uk) Халат одноразовий
TH1601003401A (th) แอนทิบอดีแอนทิ-dpep3 ที่ใหม่และวิธีการของการใช้งาน
TH1501007948A (th) ชั้น TiB2 และการใช้ของชั้น TiB2 ดังกล่าว
UA31276S (uk) Бахіла одноразова